European Multidisciplinary Meeting on Urological Cancers

Oncology Meeting Resources

24 Nov - 27 Nov, Milan, Italy

EMUC 2016 Square Image

Focusing on controversial diagnostic issues and treatment strategies, EMUC organisers harness the synergies of the European Society for Medical Oncology (ESMO), the European SocieTy for Radiotherapy & Oncology (ESTRO) and the European Association of Urology (EAU) to offer a scientific programme that directly addresses core topics and emerging trends in urological malignancies.

Here, you will find the webcasts from EMUC 2016 to the extent the presenters have consented to release their contribution or a slightly modified version thereof. Please, note that the publication of these presentations is a courtesy of the originating authors and is for personal educational purposes only.

Useful links

Presenter Presentation title Session title
Welcome and Introduction Welcome and Introduction
N. Mottet ESU Online Education - Metastatic Prostate Cancer e-course ESU Online Education - Metastatic Prostate Cancer e-course
G. De Meerleer Salvage radiotherapy for locally recurrent disease: When and how? How to use combination therapies in prostate cancer
R. Karnes How to optimize the use of adjuvant radiation therapy after radical prostatectomy: Integrating clinical and genomic features How to use combination therapies in prostate cancer
K. Fizazi What is the role of adjuvant systemic approaches after curative treatment? How to use combination therapies in prostate cancer
K. Touijer What is the best multi-modal approach for node positive disease? How to use combination therapies in prostate cancer
A. Bjartell Oligo vs polymetastatic prostate cancer: Distinct tumor entities? How to use combination therapies in prostate cancer
C. Sweeney Combined or sequential systemic treatment for castration resistant disease? How to use combination therapies in prostate cancer
M. Mason When to use chemotherapy in hormone sensitive prostate cancer How to use combination therapies in prostate cancer
R. Montironi Variants of prostate cancer: The pathologist�s point of view Focus on uro-genital cancer variants
C. Evans Prostate cancer variants in the setting of mCRPCa and their clinical implications Focus on uro-genital cancer variants
G. Martignoni Variants of renal cell carcinoma: The pathologist�s point of view Focus on uro-genital cancer variants
G. Malouf Variants of renal cell carcinoma: Clinical implications Focus on uro-genital cancer variants
A. Lopez-Beltran Variants of bladder cancer: The pathologist�s point of view Focus on uro-genital cancer variants
N. Maitland Panel Discussion and close When science meets the clinics: Genomic profiling in primary prostate cancer